**Don't have 30 minutes to watch? Find out what our experienced panel think about the future of lateral flow in this easy-to-read PDF guide. Download now.**
Lateral flow tests have been crucial in the global response to the COVID-19 pandemic and will be a major part of the world’s return to normality. But what's next for the technology?
In this live webinar, I asked three experienced commercial leaders about their insights, advice and predictions on the future of this market. Our panel included:
- Leigh Thomas - Senior VP, Director of Global Sales at Abingdon Health
- Angus Urquhart - Sales Director at Katalyst Laboratories
- Robert Miller - President of Drummond Scientific
We discussed where the future opportunity lies for lateral flow, plus how these experts are challenging the technology’s inaccurate reputation and pitching it alongside other point-of-care diagnostic solutions.
You can find the podcast episode of this by searching for CM Conversations into Spotify or Apple Music. You can also listen via the CM Life Science site too. Click to listen to What's Next for Laterafl Flow?
If you'd like to learn more about the panel or myself, feel free to get in touch via Nathan.Sharpe@lifesci-cm.com.
You can find more content about our discussion via my profile page. You'll also be able to find a similar podcast I recorded with Jonathan O’Halloran, who is CEO at QuantuMDx, which was about the broader question: What's Next for POC Diagnostics?